Asian Hematology Research Journal

Hemostatic Parameters in Women with Obstetric Hemorrhage

Jiji J S *

Department of Pathology, Govt Medical College, Kottayam, India.

Cicy PJ

Department of Pathology, Govt Medical College, Kottayam, India.

Acka Priya Varghese

Department of Obstetrics and Gynaecology, Govt Medical College, Kottayam, India.

*Author to whom correspondence should be addressed.

---

Abstract

Aims: To find out the relationships observed in hemostatic parameters during the course of obstetric hemorrhage for an effective hemostatic management and goal directed therapy.

Study Design: Analytical, Case-Control Study.

Place and Duration of Study: Department of Obstetric and Gynaecology,Department of Pathology, Govt Medical College, Kottayam, Duration:12 months.

Methodology: We included 68 cases (18-45 yrs) with obstetric hemorrhage and 68 controls (18-45 yrs, Third trimester) without Obstetric hemorrhage.Blood collected for PT,APTT,Fibrinogen and platelet count in sodium citrate and EDTA anticoagulated samples. PT, APTT, Fibrinogen assay done by Automatic methods, platelet count done in 5 part coulter machine.

Results: The study, involving 136 participants divided into case and control groups, revealed significant differences in key haemostatic parameters. The case group exhibited elevated Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) values, along with lower Platelet count and Fibrinogen concentration compared to the control group. Notably, Antepartum Hemorrhage (APH) and Postpartum Hemorrhage (PPH) showed a substantial linear relationship with platelet levels in the case group, emphasizing the potential predictive role of platelet counts in hemorrhagic events associated with obstetric conditions.

Conclusion: study sheds light on the critical link between obstetric hemorrhage and hemostatic parameters, highlighting significant variations in prothrombin time (PT), activated partial thromboplastin time (APTT), platelet count, and fibrinogen concentration between women with and without obstetric hemorrhage. The findings underscore the complexity of managing obstetric hemorrhages and the importance of laboratory-based screening in evaluating the coagulation status of affected patients.

Keywords: Maternal hemorrhage, PT, aPTT, Fibrinogen assay, Antepartum hemorrhage, post partum hemorrhage

---

---

---

References

GBD 2015. Maternal mortality collaborators. Global, regional, and national levels of maternal mortality, 1990e2015: A systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1775e812.

WHO. WHO recommendations uterotonics for the prevention of postpartum haemorrhage; 2018. Available:https://apps.who.int/iris/bitstream/handle/10665/277276/978 9241550420-eng.pdf?ua¼1

(Accessed 22 November)

Sheldon WR, Blum J, Vogel JP, et al. Postpartum haemorrhage management, risks, and maternal outcomes: Findings from the world health organization multicountry survey on maternal and newborn health. BJOG. 2014;121:5e13.

Callaghan WM, Creanga AA, Kuklina EV Severe maternal morbidity among delivery and postpartum hospitalizations in the United States. Obstet Gynecol. 2012;120:1029–36.

Grobman WA, Bailit JL, Rice MM, Wapner RJ, Reddy UM, Varner MW, et al. Frequency of and factors associated with severe maternal morbidity. Obstet Gynecol. 2014;123:804–10.

Resar, R., Grifn, FA., Haraden C, Nolan TW. Using care bundles to improve health care quality. IHI innovation series white paper. Institute for Healthcare Improvement, Cambridge, MA; 2012.

Bingham D, Lyndon A, Lagrew D, Main E. A statewide obstetric hemorrhage quality improvement initiative. MCN American Journal of Maternal Child Nursing. 2011; 36(5):297–304.

Shields LE, Wiesner S, Fulton J, Pelletreau B. Comprehensive maternal hemorrhage protocols reduce the use of blood products and improve patient safety. American Journal of Obstetrics and Gynecology. 2015;212(3):272–280.

Kramer MS, Berg C, Abenhaim H, et al. Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. American Journal of Obstetrics and Gynecology. 2013;209:e1–7.

Lutomski JE, Byrne BM, Devane D, Greene RA. Increasing trends in atonic postpartum haemorrhage in Ireland: An 11- year population-based cohort study. British Journal of Obstetrics and Gynaecology. 2012;119:306–14.

Mehrabadi A, Hutcheon JA, Lee L, Kramer MS, Liston RM, Joseph KS. Epidemiological investigation of a temporal increase in atonic postpartum haemorrhage: A population based retrospective cohort study. British Journal of Obstetrics and Gynaecology. 2013;120:853–62.

Main EK, Goffman D, Scavone BM, Low LK, Bingham D, Fontaine PL, et al. National partnership for maternal safety: consensus bundle on obstetric hemorrhage. Anesth Analg. 2015;121: 142–8.

Callaghan WM, Grobman WA, Kilpatrick SJ, Main EK, DʼAlton M. Facility-based identification of women with severe maternal morbidity: It is time to start. Obstet Gynecol. 2014;123:978–81.

Kulikowski CA, Shortliffe EH, Currie LM, Elkin PL, Hunter LE, Johnson TR, et al. AMIA Board white paper: definition of biomedical informatics and specification of core competencies for graduate education in the discipline. J Am Med Inform Assoc. 2012;19:931–8.

Goffman D, Friedman AM, Sheen JJ, Kessler A, Vawdrey D, Green R, D’Alton ME, Oberhardt M. A framework for improving characterization of obstetric hemorrhage using informatics data. Obstetrics and Gynecology. 2019 Dec 1;134(6):1317-25.

Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: Case-control study. BMJ. 2005;322:1089–93.

Royal College of Obstetricians and Gynaecologist Green top 52. Postpartum haemorrhage, prevention and management. Available: http://www.rcog.org.uk/womens-health/clinical-guidance/prevention and-management-postpartum-haemorrhage-green-top-52, 2009 [accessed 19.11.23]

Reyal F, Sibony O, Oury JF, et al. Criteria for transfusion in severe postpartum hemorrhage: Analysis of practice and risk factors. Eur J Obstet Gynaecol Reprod Biol. 2004;112:61–4.

Reyal F, Sibony O, Oury JF, et al. Criteria for transfusion in severe postpartum hemorrhage: Analysis of practice and risk factors. Eur J Obstet Gynaecol Reprod Biol. 2004;112:61–4.

British Committee for Standards, Stainsby D, MacLennan S, Thomas D, Issac J, Hamilton PJ. Guidelines on the management of massive blood loss. Br J Haematol. 2006;135:634–41.

Association of Anaesthetists of Great Britain and Ireland. Blood Transfusion and the anaesthetist. Blood component therapy. London AAGBI; 2005.

Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003;16(2):153–168.

O’Riordan MN, Higgins JR. Haemostasis in normal and abnormal pregnancy. Best Pract Res Clin Obstet Gynaecol. 2003; 17(3):385–396.

McCrae KR. Thrombocytopenia in pregnancy: Differential diagnosis, pathogenesis and management. Blood Rev. 2003;17(1):7–14.

Boehlen F, Hohlfeld P, Extermann P, Perneger TV, de Moerloose P. Platelet count at term pregnancy : Are appraisal of the threshold. Obstet Gynecol. 2000; 95(1):29–33.

Orlikowski CE, Rocke DA. Coagulation monitoring in the obstetric patient. Int Anesthesiol Clin. 1994;32(2):173–191.

Wong CA, Liu S, Glassenberg R. Comparison of thrombelastography with common coagulation tests in preeclamptic and healthy parturients. Reg Anesth. 1995;20(6):521–527.

Kozek-Langenecker SA. Perioperative coagulation monitoring. Best Pract Res Clin Anaesthesiol. 2010;24(1):27–40.

Stirling Y, Woolf L, North WR, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemost. 1984;52:176-82.

Bonnar J. Haemostasis and coagulation disorders in pregnancy. In: Bloom AL, Thomas DP, editors. Haemostasis and Thrombosis, Churchill Livingstone, Edinburgh. 1987;570-84.

Gerbasi FR, Bottoms S, Farag A, Mammen E. Increased intravascular coagulation associated with pregnancy. Obstet Gynecol. 1990;75:385–9.

Wallenburg HC, Van Kessel PH. Platelet lifespan in normal pregnancy as determined by a non-radio-isotopic technique. Br J Obstet Gynaecol. 1978;85:33-6.

Douglas JT, Shah M, Lowe GD, Belch JJ, Forbes CD, Prentice CR. Plasma fibrinopeptide A and β-thromboglobulinin pre-eclampsia and pregnancy hypertension. ThrombHaemost. 1982;47: 54-5.

Fitzgerald DJ, Mayo G, Catella F, Entman SS, FitzGerald GA. Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets. Am J Obstet Gynecol. 1987;157:325-30.

Letsky EA. Coagulation problems during pregnancy. Churchill Livingstone, Edinburgh; 1985.

Greer IA, Haemostasis and thrombosis in pregnancy. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, Editors. Haemostasis and Thrombosis (3rd ed.), Churchill Livingstone, Edinburgh. 1994;987–1015.

Francalanci I, Comeglio P, Liotta AA, Cellai AP, Fedi S, Parretti E, et al. D-dimer concentrations during normal pregnancy, as measured by ELISA. Thromb Res. 1995;78:399-405.

Beller FK, Ebert C. The coagulation andfibrinolyticenzyme systems in normal pregnancy and the puerperium. EurJ Obstet Gynecol Reprod Biol. 1982;13: 177-97.

Hellgren M, Blomback M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. Gynecol Obstet Invest. 1981;12:141-54.

Persson BL, Stenberg P, Holmberg L, Astedt B. Transamidating enzymes in maternal plasma and placenta in human pregnancies complicated by intrauterin growth retardation. J Dev Physiol. 1980;2:37-46.

Bremme K, Ostlund E, Almqvist I, Heinonen K, Blomback M. Enhanced thrombin generation and fibrinolytic activity in the normal pregnancy and the puerperium. ObstetGynecol. 1992;80:132–7.

Clark P, Brennand J, Conkie JA, McCall F, Greer IA, Walker ID. Activated protein C sensitivity. Protein C, protein S and coagulation in normal pregnancy. Thromb Haemost. 1998;79:1166-70.

Gonzales R, Alberca J, VicenteV. Protein C levels in late pregnancy, postpartum and in women on oral contraceptives. Thromb Res. 1985;39:637–40.

Gilabert J, Fernandez JA, Espana F, Aznar J, Estelles A. Physiological coagulation inhibitors (protein S, protein C and antithrombin III) in severe preeclamptic states and in users of oral contraceptives. Thromb Res. 1988;49:319-29.

Aznar J, Gilabert J, Estelles A, Espana F. Fibrinolytic activity and protein C in preeclampsia. Thromb Haemost. 1986;55:314–7.

Faught W, Garner P, Jones G, Ivey B. Changes in protein C and protein S levels in normal pregnancy. Am J ObstetGynecol. 1995;172:147-50.

Kjellberg U, Andersson NE, Rosen S, Tengborn L, Hellgren M. APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost. 1999;81:527-31.

Boffa MC, Valsecchi L, Fausto A, Gozin D, Vigano' D'Angelo S, Safa O, et al. Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension. Thromb Haemost. 1998; 79:1092–5.

De Moerloose P, Mermillod N, Amiral J, Reber G. Thrombomodulin levels during normal pregnancy at delivery and in the postpartum—comparison with tissue type plasminogen activator and plasminogen activator inhibitor-1. Thromb Haemost. 1998;79:554–6.

Comp PC, Thurnau CR, Welsh J, Esmon CT. Functional and immunologic protein S levels are decreased during pregnancy. Blood. 1986;68:881–5.

Lefkowitz JB, Clarke AH, Barbour LA. Comparison of protein S functional and antigenic assays in normal pregnancy. Am J Obstet Gynecol. 1996;175:657-60.

Uchikova EH, Ledjev II. Changes in haemostasis during normal pregnancy. Eur J Obstet Gynecol. 2005;119:185-8.

Quack Loetscher KC, Stiller R, Roos M, Zimmermann R. Protein Z in normal pregnancy. Thromb Haemost. 2005;93: 706-9.

Cumming AM, Tait RC, Fildes S, Yoong A, Keeney S, Hay CR. Development of resistance to activated protein C during pregnancy. Br J Haematol. 1995;90:725-7.

Mathonnet F, de Mazancourt P, Bastenaire B, Morot M, Benattar N, Beufe S, et al. Activated protein C sensitivity ratio in pregnant women at delivery. Br J Haematol. 1996;92:244-6.

Ishii A, Yamada R, Hamada H. t-PA activity in peripheral blood obtained from pregnant women. J Perinat Med. 1994;22:113-7.

Lecander I, Åstedt B. Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma. Br J Haematol. 1986;62:221–8.

Wright JG, Cooper P, Astedt B, Lecander I, Wilde JT, Preston FE, et al. Fibrinolysis during normal human pregnancy: complex interrelationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time. Br J Haematol. 1988;69:253-8.

Booth NA. The natural inhibitors of fibrinolysis. In: Bloom AL, Forbes CS, Thomas DP, Tuddenham EGD, editors. Haemostasis and Thrombosis, Churchill Livingstone, Edinburgh. 1994;699–717.

Åstedt B, Hägerstrand I, Lecander I. Cellular localisation in placenta of placental type plasminogen activator inhibitor. Thromb Haemost. 1986;56:63–5.

Estelles A, Gilabert J, Espana F, Aznar J, Galbis M. Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia. Am J Obstet Gynecol. 1991;165:138-42.

Paniccia R, Prisco D, Bandinelli B, Fedi S, Giusti B, Pepe G, et al. R. Plasma and serum levels of D-dimer and their correlations with other hemostatic parameters in pregnancy. Thromb Res. 2002;105: 257-62.

Francalanci I, Comeglio P, Alessandrello Liotta A, CellaiAP, Fedi S, Parretti E, et al. D-dimer plasma levels during normal pregnancy measured by specific ELISA. Int J Clin Lab Res. 1997;27:65-7.

Morse M. Establishing a normal range for D-dimer levels through pregnancy to aid in the diagnosis of pulmonary embolism and deep vein thrombosis. J Thromb Haemost. 2004;2:1202-4.

Gilabert J, Aznar J, Parrilla JJ, Reganon E, Vila V, Estelles A. Alterations in the coagulation and fibrinolysis system in pregnancy, labour and puerperium, with special reference to a possible transitory state of intravascular coagulation during labour. Thromb Haemost. 1978;40:387- 96.

Ygge J. Changes in blood coagulation and fibrinolysis during the puerperium. Am J Obstet Gynecol. 1969;104: 2–12.

Dahlstrom BL, Nesheim BI. Postpartum platelet count in maternal blood. Acta Obstet Gynecol Scand. 1994;73: 695-7.

Mannucci PM, Vigano S, Bottasso B, Candotti G, Bozzetti P, Rossi E, et al. Protein C antigen during pregnancy, deliveryand the puerperium. Thromb Haemost. 1984; 52:217.

Andersson T, Lorentzen B, Hogdahl H, Clausen T, Mowinckel MC, Abildgaard U. Thrombin-inhibitor complexes in the blood during and after delivery. Thromb Res. 1996;82:109-17.

Chavan R, Latoo MY. Recent advances in the management of major obstetric haemorrhage. Br J Med Pract. 2013;6:a604.

Varouxaki N, Gnanasambanthan S, Datta S, Amokrane N. Antepartum haemorrhage. Obstet Gynaecol Reprod Med. 2018;28:237e42.

Banks A, Norrris A. Massive haemorrhage in pregnancy. Contin Educ Anaesth Crit Care Pain. 2005;5:195-8.

Trikha A, Singh PM. Management of major obstetric haemorrhage. Indian J Anaesth. 2018;62:698-703.

RCOG. Prevention and Management of Postpartum Haemorrhage (Green-top Guideline No. 52); 2016.

Menard MK, Main EK, Currigan SM. Executive summary of the revitalize initiative: Standardizing obstetric data definitions. Obstet Gynecol. 2014;124:150e3.

Hayes N, Drew T. Cardiopulmonary physiological alterations in pregnancy. In: Lapinsky S, Plante L, editors. Respiratory Disease in Pregnancy. Cambridge, UK: Cambridge University Press. 2020;25e33.

Drew T, Carvalho JC. Major obstetric haemorrhage. BJA education. 2022 Jun;22(6):238.

Bell SF, Watkins A, John M, et al. Incidence of postpartum haemorrhage defined by quantitative blood loss measurement: A national cohort. BMC Pregnancy Childbirth. 2020;20:271.

Obstetric Anaesthetists’ Association and Association of Anaesthetists of Great Britain and Ireland. OAA/AAGBI Guidelines for Obstetric Anaesthesia Services; 2013. Available: http://www.aagbi.org/sites/default/files/obstetric_anaesthetic_services_2013.pdf

Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu DC, et al. Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013;30:270-382.

Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. Journal of Thrombosis and Haemostasis. 2007;5:266–73.

De Lloyd L, Bovington R, Kaye A, et al. Standard haemostatic tests following major obstetric haemorrhage. International Journal of Obstetric Anesthesia. 2011; 20:135–41.

Collins PW, Lilley G, Bruynseels D, et al. Fibrin-based clot formation an early and rapidly biomarker for progression of postpartum hemorrhage: A prospective study. Blood. 2014;124:1727–36.

Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesthesia and Analgesia. 1995;81:360–5.

Allard S, Green L, Hunt BJ. How we manage the haematological aspects of major obstetric haemorrhage. British Journal of Haematology 2014;164:177–88.

Thachil J, Toh CH. Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Reviews. 2009;23:167–76.

Levi, Marcel. Pathogenesis and management of peripartum coagulopathic calamities (disseminated intravascular coagulation and amniotic fluid embolism). Thrombosis Research. 2013;131:S32-S34.

Solomon C, Collis RE, Collins PW. Haemostatic monitoring during postpartum haemorrhage and implications for management. British Journal of Anaesthesia. 2012;109:851–63.

De Lange NM, Lance MD, De Groot R, Beckers EAM, Henskens YM, Scheepers HCJ. Obstetric hemorrhage and coagulation: An update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. Obstetrical and GynecologicalSurvey. 2012;67:426–35.

Hill JS, Devenie G, Powell M. Point-of-care testing of coagulation and fibrinolytic status during postpartum haemorrhage: Developing a thrombelastography guided transfusion algorithm. Anaesthesia and Intensive Care. 2012;40:1007– 15.

Van Rheenen-Flach LE, Zweegman S, Boersma F, Lenglet JE, Twisk JWR, Bolte AC. A prospective longitudinal study on rotation thromboelastometry in women with uncomplicated pregnancies and postpartum. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2013;53:32–6.

Huissoud C, Carrabin N, Audibert F, et al. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. International Journal of Obstetrics and Gynaecology. 2009; 116:1097–102.

Hill JS, Devenie G, Powell M. Point-of-care testing of coagulation and fibrinolytic status during postpartum haemorrhage: Developing a thrombelastography guided transfusion algorithm. Anaesthesia and Intensive Care. 2012;40:1007– 15.

Erhabor O, Isaac IZ, Muhammad AM, Abdulrahaman Y, Ezimah AC, Adias TC. Some hemostatic parameters in women with obstetric hemorrhage in Sokoto, Nigeria. International journal of women's health. 2013 Jun 14:285-91.

Solomon C, Collis RE, Collins PW. Haemostatic monitoring during postpartum haemorrhage and implications for management. Br J Anaesth. 2012;109(6):851–863.

De Lloyd L, Bovington R, Kaye A, et al. Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth. 2011;20(2):135–141.

Charbit B, Mandelbrot L, Samain E, et al; PPH Study Group. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007;5(2):266–273.

Gayat E, Resche-Rigon M, Morel O, et al. Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study. Intensive Care Med. 2011;37(11):1816–1825.

Arulkumaran S, Mavrides E, Penney GC. Prevention and management of postpartum haemorrhage. Royal College of Obstetricians and Gynaecologists. Green-top guideline 52; 2009.

Simon L, Santi TM, Sacquin P, Hamza J. Pre-anaesthetic assessment of coagulation abnormalities in obstetric patients: Usefulness, timing and clinical implications. Br J Anaesth. 1997;78(6): 678–683.

Cherkas D. Traumatic hemorrhagic shock: Advances in fluid management. Emerg Med Pract. 2011;13(11):1–19; quiz 19–20.

Boehlen F. Thrombocytopenia during pregnancy. Importance, diagnosis and management. Hamostaseologie. 2006; 26(1):72–74;quiz 75–78.

Davies T, Catling S, Grainger HR. Re: Intraoperative cell salvage in obstetrics by Hannah Grainger and Sue Catling. J Perioper Pract. 2011;21(12):400.

Patriquin C, Crowther M. Treatment of warfarin-associated coagulopathy with vitamin K. Expert Rev Hematol. 2011; 4(6):657–665;quiz 666–667.

Laguna P, Klukowska A. Management of oral bleedings with recombinant factor VIIa in children with haemophilia A and inhibitor. Haemophilia. 2005;11(1): 2–4.

Mauser-Bunschoten EP, Koopman MM, Goede-Bolder AD, et al; Recombinant Factor VIIa Data Collection Group. Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitors. Haemophilia. 2002;8(5): 649–656.

Domenico prisco, Gabriele ciuti, Michela falciani. Hemostatic changes in normal pregnancy. [haematologica reports] 2005;1(10):1-5.